Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer

NCT03492671 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Adenocarcinoma
Resectable Pancreatic Cancer

Interventions

DRUG: Gemcitabine 1000 mg
DRUG: nab-paclitaxel
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Loma Linda University